Seeking Alpha

Haemonetics (HAE -1%) slips on a limp coverage intiation from Goldman Sachs this morning,...

Haemonetics (HAE -1%) slips on a limp coverage intiation from Goldman Sachs this morning, starting the shares with a Neutral rating and a price target of $47.00. Goldman says the stock is already trading at a premium to both the S&P 500 and its sector peers, and it "limited upside to consensus numbers with management's longterm guidance already contemplating top-line growth ahead of recent trends."
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|